Insulet (PODD) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.89% |
| Dec 31, 2025 | 5.41% |
| Sep 30, 2025 | 20.40% |
| Jun 30, 2025 | 5.28% |
| Mar 31, 2025 | 18.17% |
| Dec 31, 2024 | 20.11% |
| Sep 30, 2024 | 22.36% |
| Jun 30, 2024 | 15.42% |
| Mar 31, 2024 | 19.61% |
| Dec 31, 2023 | 15.07% |
| Sep 30, 2023 | -8.18% |
| Jun 30, 2023 | 13.56% |
| Mar 31, 2023 | 8.14% |
| Dec 31, 2022 | 6.05% |
| Sep 30, 2022 | 0.23% |
| Jun 30, 2022 | 8.26% |
| Mar 31, 2022 | 5.93% |
| Dec 31, 2021 | 4.91% |
| Sep 30, 2021 | 6.21% |
| Jun 30, 2021 | 10.30% |
| Mar 31, 2021 | 10.29% |
| Dec 31, 2020 | 23.98% |
| Sep 30, 2020 | 9.35% |
| Jun 30, 2020 | 6.04% |
| Mar 31, 2020 | 8.29% |
| Dec 31, 2019 | 13.37% |
| Sep 30, 2019 | -7.35% |
| Jun 30, 2019 | 14.50% |
| Mar 31, 2019 | 5.87% |
| Dec 31, 2018 | 16.90% |
| Sep 30, 2018 | 40.33% |
| Jun 30, 2018 | 12.50% |
| Mar 31, 2018 | 22.26% |
| Dec 31, 2017 | 28.10% |
| Sep 30, 2017 | 31.07% |
| Jun 30, 2017 | 24.68% |
| Mar 31, 2017 | 22.25% |
| Dec 31, 2016 | 25.96% |
| Sep 30, 2016 | 27.50% |
| Jun 30, 2016 | 25.09% |
| Mar 31, 2016 | 21.87% |
| Dec 31, 2015 | 36.91% |
| Sep 30, 2015 | 27.12% |